MX2019006845A - Proceso. - Google Patents

Proceso.

Info

Publication number
MX2019006845A
MX2019006845A MX2019006845A MX2019006845A MX2019006845A MX 2019006845 A MX2019006845 A MX 2019006845A MX 2019006845 A MX2019006845 A MX 2019006845A MX 2019006845 A MX2019006845 A MX 2019006845A MX 2019006845 A MX2019006845 A MX 2019006845A
Authority
MX
Mexico
Prior art keywords
efficient
product obtained
high temperatures
tertiary alcohols
complex alcohol
Prior art date
Application number
MX2019006845A
Other languages
English (en)
Inventor
David Gavin Paul
Geytenbeek Stephen
Stirling Andrew
Original Assignee
Avecho Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2016905298A external-priority patent/AU2016905298A0/en
Application filed by Avecho Biotechnology Ltd filed Critical Avecho Biotechnology Ltd
Publication of MX2019006845A publication Critical patent/MX2019006845A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/095—Compounds containing the structure P(=O)-O-acyl, P(=O)-O-heteroatom, P(=O)-O-CN
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/11—Esters of phosphoric acids with hydroxyalkyl compounds without further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Un proceso de fosforilación eficiente y comercial de un alcohol complejo, tal como los alcoholes secundarios y terciarios, con P4O10 a altas temperaturas, y un producto que se obtiene mediante el proceso.
MX2019006845A 2016-12-21 2017-12-13 Proceso. MX2019006845A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2016905298A AU2016905298A0 (en) 2016-12-21 Process
PCT/AU2017/051381 WO2018112512A1 (en) 2016-12-21 2017-12-13 Process

Publications (1)

Publication Number Publication Date
MX2019006845A true MX2019006845A (es) 2019-10-15

Family

ID=62624385

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019006845A MX2019006845A (es) 2016-12-21 2017-12-13 Proceso.

Country Status (11)

Country Link
US (2) US20190330260A1 (es)
EP (1) EP3558903A4 (es)
JP (1) JP7198754B2 (es)
KR (1) KR102647670B1 (es)
CN (1) CN110662733A (es)
AU (2) AU2017381395A1 (es)
BR (1) BR112019012946A2 (es)
CA (1) CA3045702A1 (es)
IL (1) IL267006A (es)
MX (1) MX2019006845A (es)
WO (1) WO2018112512A1 (es)

Family Cites Families (301)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2407823A (en) 1946-09-17 Antihemorrhagic esters and methods
US2457932A (en) 1949-01-04 Salts of tocopheryl phosphoric
US2667479A (en) 1951-01-30 1954-01-26 Merck & Co Inc Benzimidazole phosphate
GB778142A (en) 1953-11-20 1957-07-03 Leo Ab High-molecular weight derivatives of hydroxyl group-containing steroids and a method of producing them
US2913477A (en) 1957-03-22 1959-11-17 Merck & Co Inc Antihemorrhagic compounds and processes for preparing the same
US3127434A (en) 1959-10-20 1964-03-31 Hoffmann La Roche Dihydrovitamin k monophosphate compounds and preparation thereof
US3212901A (en) 1961-06-07 1965-10-19 Eastman Kodak Co Stabilized tocopherol concentrates and process for preparing the same
US3331896A (en) 1964-09-15 1967-07-18 Gen Aniline & Film Corp Method of preparing alkali soluble phosphate esters of hydroxylic organic compounds
US3607765A (en) 1968-11-29 1971-09-21 Colgate Polmolive Co Detergent softener compositions
JPS5022535A (es) 1973-06-27 1975-03-11
DE2526938C2 (de) 1975-02-14 1982-04-22 F. Hoffmann-La Roche & Co. AG, 4002 Basel Vitaminpräparate
JPS521858A (en) 1975-06-24 1977-01-08 Hitachi Metals Ltd Steel pipe transfer apparatus
JPS5239013A (en) 1975-09-23 1977-03-26 Shintaro Yamada Forced draft diesel engine
JPS6035347B2 (ja) 1976-07-26 1985-08-14 エーザイ株式会社 α−トコフエロ−ルの合成法
US4141938A (en) * 1976-10-07 1979-02-27 Hoechst Aktiengesellschaft Production of acid orthophosphoric acid ester mixtures
US4444755A (en) 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
US4299906A (en) 1979-06-01 1981-11-10 American Hoechst Corporation Light-sensitive color proofing film with surfactant in a light-sensitive coating
SU925961A1 (ru) 1980-08-15 1982-05-07 Московский ордена Трудового Красного Знамени технологический институт пищевой промышленности Способ получени фосфорилированных глицеридов высших жирных кислот
US4369172A (en) 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
IT1157269B (it) 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
JPS58180410A (ja) 1982-04-16 1983-10-21 Shiseido Co Ltd 化粧料
JPS5944375A (ja) 1982-09-06 1984-03-12 Senjiyu Seiyaku Kk α−トコフエロ−ルリン酸エステルの安定な水溶液
JPH0247997B2 (ja) 1983-02-25 1990-10-23 Sanyo Chemical Ind Ltd Rinsanesuterunoseizoho
JPS6048962A (ja) 1983-08-26 1985-03-16 Chisso Corp スルファミン酸グアニジンの製造方法
JPS6056699A (ja) 1983-09-08 1985-04-02 三菱重工業株式会社 半暖水双銅船
JPS60197621A (ja) 1984-03-19 1985-10-07 Hohnen Oil Co Ltd コレステロ−ル低下剤
CH661438A5 (it) 1984-04-09 1987-07-31 Seuref Ag Composizioni farmaceutiche ad azione antianossica e metabolica cerebrale.
US4977282A (en) 1984-04-17 1990-12-11 Henkel Corporation Production of d-alpha-tocopherol from natural plant sources
US4603142A (en) 1984-06-01 1986-07-29 Wisconsin Alumni Research Foundation Cholesterol lowering method of use
DE3582904D1 (de) 1984-08-02 1991-06-27 Henkel Corp Reinigung von tocopherolen durch extraktion.
JPS6186940A (ja) 1984-10-02 1986-05-02 Kao Corp 水中油型乳化組成物
JPS6191137A (ja) 1984-10-11 1986-05-09 Kao Corp 外用薬剤組成物
JPS61176535A (ja) 1985-01-31 1986-08-08 Morishita Jintan Kk 腸溶性製剤
JP2540294B2 (ja) 1985-04-09 1996-10-02 花王株式会社 経皮吸収製剤
JPS62195393A (ja) 1986-02-21 1987-08-28 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造方法
JPS6393791A (ja) 1986-10-08 1988-04-25 Nippon Shokubai Kagaku Kogyo Co Ltd リン酸エステルおよびその製法
JPH0781138B2 (ja) 1986-12-02 1995-08-30 株式会社資生堂 抗酸化剤
DE3702766A1 (de) * 1987-01-30 1988-08-11 Henkel Kgaa Verfahren zur herstellung und isolierung von monoalkylphosphorsaeureestern
JP3070744B2 (ja) 1987-04-10 2000-07-31 株式会社日立製作所 ベクトル処理装置
US4952495A (en) 1987-06-08 1990-08-28 Eastman Kodak Company Hydrolyzable compounds which release electron transfer agents and analytical use of same
PH25859A (en) 1988-01-11 1991-12-02 Takeda Chemical Industries Ltd Composition for treatment of ischemic disorder
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
JPH01228920A (ja) 1988-03-09 1989-09-12 Kuraray Co Ltd 吸収促進剤
DE3813624A1 (de) 1988-04-22 1989-11-02 Basf Ag Verfahren zur herstellung von d-(alpha)-tocopherol aus natuerlichen vorprodukten
JPH01274830A (ja) 1988-04-28 1989-11-02 Asahi Denka Kogyo Kk 安全で且つ高度な界面活性を有する脂質組成物
CA2007643A1 (en) 1989-02-01 1990-08-01 Donald S. Karanewsky Combination of an hmg coa reductase inhibitor and a squalene synthetase inhibitor and method for lowering serum cholesterol using such combination
US6028105A (en) 1989-04-06 2000-02-22 Nigra; Thomas P. Topical drug delivery composition and method
JP3040427B2 (ja) 1989-05-18 2000-05-15 帝國製薬株式会社 神経痛治療用アスピリン含有軟膏組成物
US5053222A (en) 1989-06-07 1991-10-01 Shiseido Company Ltd. Hair cosmetic composition
US5094848A (en) 1989-06-30 1992-03-10 Neorx Corporation Cleavable diphosphate and amidated diphosphate linkers
DE3927113C2 (de) 1989-08-17 1993-11-25 Dolorgiet Gmbh & Co Kg Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
JPH03120230A (ja) 1989-10-04 1991-05-22 Nippon Mining Co Ltd 薬効成分の経皮吸収促進剤及び経皮吸収型製剤
JP2854631B2 (ja) 1989-11-21 1999-02-03 千寿製薬株式会社 糖尿病合併症および老化によって引き起こされる疾患の予防・治療剤
IT1236843B (it) 1989-11-22 1993-04-21 Simes Processo per la preparazione di 4-0-fosfati di dopamina o suoi derivati
JPH03206089A (ja) 1990-01-05 1991-09-09 Eisai Co Ltd 新規ビタミンｅ誘導体及びその製造方法
US5374645A (en) 1990-01-22 1994-12-20 Ciba-Geigy Corporation Transdermal administation of ionic pharmaceutically active agents via aqueous isopropanol
FR2657526B1 (fr) 1990-01-31 1994-10-28 Lvmh Rech Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues.
US5041434A (en) 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
US5114957A (en) 1990-05-08 1992-05-19 Biodor U.S. Holding Tocopherol-based antiviral agents and method of using same
NZ238202A (en) 1990-05-21 1994-01-26 Smith Kline French Lab Pyridine and benzene derivatives and medicaments.
JP3765579B2 (ja) 1990-08-24 2006-04-12 イーデーエーアー アーゲー 作用物質投与用超微小滴状調剤
DE69024370T2 (de) 1990-10-26 1996-06-20 Shiseido Co Ltd Hautpräparat zur äusserlichen anwendung
SE9003665D0 (sv) 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
JP3035742B2 (ja) 1990-11-30 2000-04-24 昭和電工株式会社 化粧品
JP2983311B2 (ja) 1991-02-26 1999-11-29 株式会社資生堂 皮膚外用剤
US5646190A (en) 1991-03-01 1997-07-08 Warner-Lambert Company Acne treating-wound healing compositions and methods for preparing and using same
JPH05946A (ja) 1991-06-27 1993-01-08 Nichiban Co Ltd ケトチフエン含有経皮吸収製剤
FR2679904A1 (fr) 1991-08-01 1993-02-05 Lvmh Rech Utilisation d'un phosphate de tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, ou pharmaceutiques et compositions ainsi obtenues.
US5643597A (en) 1991-08-01 1997-07-01 Lvmh Recherche Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained
EP0535283A1 (en) 1991-10-02 1993-04-07 Merrell Dow Pharmaceuticals Inc. Cardioprotective tocopherol analogs
US5474891A (en) 1991-10-30 1995-12-12 Thomas Jefferson University Plasma-based platelet concentrate preparations with additive
ES2136093T3 (es) 1991-11-11 1999-11-16 Hisamitsu Pharmaceutical Co Fomentacion que contiene cetorolac.
EP0543417A1 (en) 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotrienols and tocotrienol-like compounds and methods for their use
US5282312A (en) 1991-12-31 1994-02-01 Tessera, Inc. Multi-layer circuit construction methods with customization features
AU3662093A (en) 1992-02-14 1993-09-03 Robert Lamb Phosphate derivatives of vitamin e to protect cells from effects of aging and injury
JP3207494B2 (ja) 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
JPH05286848A (ja) 1992-04-10 1993-11-02 Senju Pharmaceut Co Ltd 浴用剤
US5731299A (en) 1992-05-29 1998-03-24 The Procter & Gamble Company Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
GB9212450D0 (en) 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
US5741518A (en) 1992-08-03 1998-04-21 L'oreal Composition composed of an aqueous dispersion of stabilized vesicles of nonionic amphiphilic lipids
US5773457A (en) 1995-02-15 1998-06-30 Cesar Roberto Dias Nahoum Compositions
AU5171293A (en) 1992-10-14 1994-05-09 Regents Of The University Of Colorado, The Ion-pairing of drugs for improved efficacy and delivery
US6384043B1 (en) 1993-02-01 2002-05-07 Gholam A. Peyman Methods of alleviating pain sensations of the denuded eye with opioid analgesics
TW252918B (es) 1993-03-31 1995-08-01 Senju Pharma Co
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
JP3179629B2 (ja) 1993-06-24 2001-06-25 花王株式会社 液体洗浄剤組成物
CN1077800C (zh) 1993-07-01 2002-01-16 韩美药品工业株式会社 环孢菌素软胶囊组合物
GB9318271D0 (en) 1993-09-03 1993-10-20 Scotia Holdings Plc Tocopherols
CA2129509A1 (en) 1993-09-10 1995-03-11 Kazumi Ogata Pharmaceutical composition for renal disorder and a dialysis solution for extracorporeal hemodialysis
WO1995014457A1 (en) 1993-11-27 1995-06-01 Knoll Ag Compositions comprising iminium ion scavengers and/or nitrite scavengers
JPH07196516A (ja) 1993-12-29 1995-08-01 Senju Pharmaceut Co Ltd 痔疾患治療剤
FR2714595B1 (fr) 1993-12-30 1996-02-02 Oreal Emulsion eau dans huile contenant du rétinol, son utilisation et son conditionnement.
JPH07207298A (ja) 1994-01-21 1995-08-08 Nippon Oil & Fats Co Ltd 洗浄剤組成物
FR2715565B1 (fr) 1994-01-31 1996-03-15 Oreal Composition cosmétique ou dermatologique stabilisée contenant plusieurs précurseurs d'un même actif pour maximaliser sa libération, son utilisation.
EP0669132A1 (en) 1994-02-23 1995-08-30 van der Kraaij, Antonius Marinus Maria Pharmaceutical composition of vitamin E and acetylsalicylate for treatment and prevention of atherosclerosis
CA2145229A1 (en) 1994-03-29 1995-09-30 Tetsuya Toge Suppressory compositions against hepatic metastases of tumors
ATE388122T1 (de) * 1994-03-30 2008-03-15 Rhodia Phosphorylierungsreagens, verfahren und verwendung
US5554781A (en) * 1994-03-30 1996-09-10 Reierson; Robert L. Monoalkyl phosphonic acid ester production process
JPH07277988A (ja) 1994-04-05 1995-10-24 Senju Pharmaceut Co Ltd 局所用掻痒除去、治療剤
JPH07278587A (ja) 1994-04-06 1995-10-24 Kao Corp 洗浄剤組成物
TW287103B (es) 1994-04-22 1996-10-01 Senju Pharma Co
JP3362501B2 (ja) 1994-04-28 2003-01-07 千寿製薬株式会社 角膜障害治療剤
JP3396953B2 (ja) 1994-05-10 2003-04-14 千寿製薬株式会社 網膜疾患予防・治療剤
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
JPH07316170A (ja) 1994-05-24 1995-12-05 Kao Corp リン酸モノエステルの製造法
WO1995034303A1 (en) 1994-06-13 1995-12-21 Arcturus Pharmaceutical Corporation Method for the treatment, prevention or minimization of hair loss
US5589504A (en) 1994-07-26 1996-12-31 Cornell Research Foundation, Inc. Treatment of newborn jaundice
CA2152693A1 (en) 1994-08-05 1996-02-06 Kazumi Ogata Therapeutic composition for pancreatitis
IT1274734B (it) 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
JPH0873338A (ja) 1994-09-02 1996-03-19 Noevir Co Ltd 皮膚外用剤
HU215966B (hu) 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
DE69532295T2 (de) * 1994-12-09 2004-09-23 Kao Corp. Verfahren zur herstellung von phosphorsäuremonoestern
JP3558757B2 (ja) * 1994-12-09 2004-08-25 花王株式会社 リン酸エステルの製造法
DE4444238A1 (de) 1994-12-13 1996-06-20 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden
SE9404568L (sv) 1994-12-30 1996-07-01 Perstorp Ab Användning av inositoltrisfosfat för beredning av läkemedel
AU4515996A (en) 1995-01-09 1996-07-31 Alpha-Therapeutics, Inc. Methods for increasing the bioavailability of biological active agents
JP3526940B2 (ja) 1995-01-11 2004-05-17 花王株式会社 リン酸エステルの製造法
FR2730928B1 (fr) 1995-02-23 1997-04-04 Oreal Composition a base de vesicules lipidiques a ph acide et son utilisation en application topique
JPH08231564A (ja) 1995-02-28 1996-09-10 Nippon Shokubai Co Ltd リン酸エステルおよびその製造方法並びにリン酸エステル重合体
GB9505025D0 (en) 1995-03-13 1995-05-03 Medical Res Council Chemical compounds
ATE249819T1 (de) 1995-04-21 2003-10-15 Seikisui Chemical Co Ltd Präparate zur äusserlichen anwendung zur behandlung von dermatosen
JP3197787B2 (ja) 1995-05-17 2001-08-13 花王株式会社 分岐二量化アルキルリン酸塩基性アミノ酸塩の製造方法
JPH08311489A (ja) 1995-05-19 1996-11-26 Nippon Oil & Fats Co Ltd 洗浄剤組成物
US5665389A (en) 1995-05-24 1997-09-09 University Of Maryland At Baltimore Oral dosage composition for intestinal delivery and method of treating diabetes
JP3622267B2 (ja) 1995-05-31 2005-02-23 日本油脂株式会社 洗浄剤組成物
US5607968A (en) 1995-06-07 1997-03-04 Avon Products, Inc. Topical alkyl-2-O-L-ascorbyl-phosphates
WO1997002803A1 (fr) 1995-07-12 1997-01-30 Shiseido Co., Ltd. Preparation externe pour la peau
JPH0944375A (ja) 1995-07-26 1997-02-14 Hitachi Ltd テストプログラムの自動テスト項目選択方式
EP0798305B1 (en) 1995-10-17 2007-10-03 Showa Denko Kabushiki Kaisha High-purity tocopherol phosphates, process for the preparation thereof, method for analysis thereof, and cosmetics
FR2741263B1 (fr) 1995-11-22 1997-12-26 Oreal Composition comprenant une dispersion aqueuse de vesicules lipidiques encapsulant un filtre uv a fonction acide et utilisations en application topique
CN1229114C (zh) 1996-03-27 2005-11-30 印斯拜尔药品股份有限公司 用三磷酸尿苷和相关化合物治疗纤毛运动障碍的方法
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US5885595A (en) 1996-05-13 1999-03-23 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic composition with a retinol fatty acid ester
JPH09309813A (ja) 1996-05-22 1997-12-02 Nonogawa Shoji Kk 皮膚外用剤
JPH1045783A (ja) 1996-07-29 1998-02-17 Showa Denko Kk ヒドロキシクロマン誘導体リン酸エステルの製造方法
CA2209690A1 (en) 1996-07-31 1998-01-31 Sachiko Matsuura Therapeutic drug for acne vulgaris
JPH1067639A (ja) 1996-08-26 1998-03-10 Shiseido Co Ltd ビタミンｅ−ビタミンｃリン酸ジエステル／シクロデキストリン包接物及び該包接物を配合した皮膚外用剤
US6022867A (en) 1996-11-27 2000-02-08 Showa Denko Kabushiki Kaisha Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals
JPH10155429A (ja) 1996-11-27 1998-06-16 Showa Denko Kk 動物に対するビタミンｅ供給方法および動物用トコフェロールリン酸エステル又はその塩類組成物
US6727280B2 (en) 1997-01-07 2004-04-27 Sonus Pharmaceuticals, Inc. Method for treating colorectal carcinoma using a taxane/tocopherol formulation
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US5804168A (en) 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
EP0965328B1 (en) 1997-01-29 2009-03-04 Kao Corporation Cosmetic
KR100563764B1 (ko) 1997-03-13 2006-03-24 헥살 아게 아미노산과 시클로덱스트린과의 병용에 의한 산(酸) 민감성 벤즈이미다졸류의 안정화 방법
US7179486B1 (en) 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
JP2926046B2 (ja) 1997-06-04 1999-07-28 株式会社太平洋 水安定型ｌ−アスコルビン酸誘導体とその製造方法及びこれを含有する美白化粧料組成物
US5928631A (en) 1997-06-09 1999-07-27 The Procter & Gamble Company Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins
US5906811A (en) 1997-06-27 1999-05-25 Thione International, Inc. Intra-oral antioxidant preparations
JPH1143436A (ja) 1997-07-25 1999-02-16 Showa Denko Kk 末梢血流障害予防・治療剤
US5776915A (en) 1997-08-12 1998-07-07 Clarion Pharmaceuticals Inc. Phosphocholines of retinoids
US6096326A (en) 1997-08-15 2000-08-01 Scandinavian-American Import/Export Corporation Skin care compositions and use
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
JP3950216B2 (ja) 1997-12-26 2007-07-25 日本メナード化粧品株式会社 皮膚外用剤
JP2001527083A (ja) 1997-12-31 2001-12-25 ザ・ユニバーシティ・オブ・カンザス 第二級および第三級アミン含有薬剤の水溶性プロドラッグおよびその製造方法
JPH11199465A (ja) 1998-01-07 1999-07-27 Nonogawa Shoji Kk 皮膚外用剤
AU2455199A (en) 1998-01-12 1999-07-26 Betagene, Inc. Compositions and methods for regulated secretion from neuroendocrine cell lines
EP1053749A4 (en) 1998-02-03 2003-01-15 Senju Pharma Co PREVENTION AND MEDICINE FOR NEURODEGENERATIVE DISEASES
FR2777179A1 (fr) 1998-04-09 1999-10-15 Lvmh Rech Compositions cosmetiques ou dermatologiques comprenant un vehicule a base d'un liquide hydrophobe
US6461623B2 (en) 1998-04-13 2002-10-08 Kao Corporation Cosmetic composition
US6254853B1 (en) 1998-05-08 2001-07-03 Vyrex Corporation Water soluble pro-drugs of propofol
US6121249A (en) 1998-07-01 2000-09-19 Donald L. Weissman Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins
DK1094781T3 (da) 1998-07-07 2008-11-03 Transdermal Technologies Inc Præparater til hurtig og ikke-irriterende transdermal administration af farmaceutisk aktive midler og fremgangsmåder til formulering af sådanne præparater samt administration deraf
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
US6703384B2 (en) 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
US6770672B1 (en) 1998-09-23 2004-08-03 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
CA2345079C (en) 1998-09-23 2011-06-21 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
US6153582A (en) 1998-11-05 2000-11-28 Bausch & Lomb Surgical, Inc. Defined serumfree medical solution for ophthalmology
IT1303787B1 (it) 1998-11-25 2001-02-23 Maria Rosa Gasco "nanosfere lipidiche solide atte ad una rapida internalizzazione nellecellule"
US6048891A (en) 1998-12-17 2000-04-11 Loma Linda University Medical Center Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of natriuretic disease
AUPP829399A0 (en) 1999-01-25 1999-02-18 Swig Pty Ltd Recovery for chroman derivatives
AUPQ037499A0 (en) * 1999-05-14 1999-06-10 Swig Pty Ltd Improved process for phosphorylation and compounds produced by this method
AU766255B2 (en) 1999-01-25 2003-10-09 Vital Health Sciences Pty Ltd Improved process for phosphorylation and compounds produced by this process
JP2000212082A (ja) 1999-01-26 2000-08-02 Showa Denko Kk 皮膚用剤
NZ527924A (en) 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
US6156354A (en) 1999-01-29 2000-12-05 Brandeis University Hyper-absorption of vitamin E dispersed in milks
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
DE19912798C1 (de) 1999-03-10 2000-02-17 Andreas Jordan Verfahren zur Kultivierung von Krebszellen aus Humangewebe und Vorrichtung zur Aufbereitung von Gewebeproben
WO2000057876A1 (en) 1999-03-26 2000-10-05 Lipogenics, Inc. Novel antioxidant formulations and methods for using them
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
BR0011523B1 (pt) * 1999-05-14 2014-09-30 Vital Health Sciences Pty Ltd Processo para a fosforilação de um álcool complexo
US6184247B1 (en) 1999-05-21 2001-02-06 Amway Corporation Method of increasing cell renewal rate
DE19923551A1 (de) 1999-05-21 2000-11-30 Lohmann Therapie Syst Lts Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
US6641847B1 (en) 1999-06-01 2003-11-04 Ocean Spray Cranberries, Inc. Cranberry seed oil extract and compositions containing components thereof
WO2000074684A1 (en) 1999-06-04 2000-12-14 The General Hospital Corporation Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use
NZ517833A (en) 1999-08-20 2004-01-30 Ferrosan As Oral delivery of antioxidants vitamin C and vitamin E combinations in slow- and plain-release formulations for treating oxidative stress
US6669951B2 (en) 1999-08-24 2003-12-30 Cellgate, Inc. Compositions and methods for enhancing drug delivery across and into epithelial tissues
US6423742B1 (en) 1999-09-02 2002-07-23 Drake Larson Compositions for reducing vascular plaque formation and methods of using same
GB9921960D0 (en) 1999-09-16 1999-11-17 Pharmacia & Upjohn Spa Formulations for parenteral use of estramustine phosphate and amino acids
US6479540B1 (en) 1999-09-27 2002-11-12 Sonus Pharmaceuticals, Inc. Compositions of tocol-soluble therapeutics
EP1265638A1 (en) 1999-11-12 2002-12-18 Pharmaderm Laboratories Ltd. Compositions for transdermal and transmucosal administration of therapeutic agents
CN100409847C (zh) 1999-11-19 2008-08-13 美国爱科赛尔制药有限公司 乌头属生物碱经皮给药系统
JP2001169731A (ja) 1999-12-17 2001-06-26 Showa Denko Kk 動物体の脂質代謝改善剤
JP2003518128A (ja) 1999-12-22 2003-06-03 メルク フロスト カナダ アンド カンパニー タンパク質チロシンホスファターゼ１ｂ（ｐｔｐ−１ｂ）のインヒビターとなる芳香族ホスホネート
IT1317736B1 (it) 2000-01-26 2003-07-15 A C R Applied Coating Res S A Cerotto per la somministrazione locale e transdermica di principiattivi dotati di gruppi anionici ed elettronattrattori.
NZ520798A (en) 2000-02-11 2004-05-28 Res Dev Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
US6635253B2 (en) 2000-02-29 2003-10-21 Showa Denko Kabushiki Kaisha Composition for enhancing immunological effects
US6346544B2 (en) 2000-03-02 2002-02-12 Oklahoma Medical Research Foundation Desmethyl tocopherols for protecting cardiovascular tissue
JP2001247585A (ja) 2000-03-03 2001-09-11 Nof Corp トコフェロール誘導体、その中間体、その製造方法及び用途
US6444220B2 (en) 2000-03-16 2002-09-03 Teresa S. Wiley Method and compositions for changing the contour of skin
JP2003528141A (ja) 2000-03-24 2003-09-24 ベーカー ノートン ファーマシューティカルズ インコーポレイテッド タキサンに基づく組成物および使用方法
US6361800B1 (en) 2000-04-13 2002-03-26 Cooper Concepts, Inc. Multi-vitamin and mineral supplement
DE10032301A1 (de) 2000-07-04 2002-01-17 Rbs Netkom Gmbh Fahrdatengewinnungs-, übermittlungs- und ausgabesystem
FR2811546B1 (fr) 2000-07-13 2003-09-26 Oreal Kit et procede de maquillage longue tenue
US6485950B1 (en) 2000-07-14 2002-11-26 Council Of Scientific And Industrial Research Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions
US6362234B1 (en) 2000-08-15 2002-03-26 Vyrex Corporation Water-soluble prodrugs of propofol for treatment of migrane
KR100365070B1 (ko) 2000-08-29 2002-12-16 주식회사 태평양 토코페롤 유도체 및 그의 제조방법
JP4818500B2 (ja) 2000-09-05 2011-11-16 株式会社ペンタプラストア トコトリエノール誘導体及びその製造方法
WO2002026238A1 (en) 2000-09-26 2002-04-04 Vital Health Sciences Pty Ltd. Phosphate derivative supplements
US6660306B2 (en) 2000-10-12 2003-12-09 Mickey L. Peshoff Wound healing compound
US20030206972A1 (en) 2000-10-13 2003-11-06 Babish John G. Compositions containing carotenoids and tocotrienols and having synergistic antioxidant effect
US20020170080A1 (en) 2000-11-02 2002-11-14 The Regents Of The University Of California Alpha-tocopherol transfer protein knockout animals
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
KR100612398B1 (ko) * 2000-11-14 2006-08-16 바이탈 헬스 사이언시즈 피티와이 리미티드 포스페이트 유도체의 착체
EP1339412B1 (en) * 2000-11-14 2011-11-02 Vital Health Sciences Pty Ltd. Formulation containing phosphate derivatives of electron transfer agents
WO2002039996A2 (en) 2000-11-16 2002-05-23 Pharmacia & Up John Company Combined therapy against tumors comprising estramustine phosphate and lhrh agonists or antagonists
IN188917B (es) 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
AU2002239748A1 (en) 2000-12-15 2002-06-24 Galileo Laboratories, Inc. Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia
US20020151467A1 (en) 2000-12-21 2002-10-17 Leung Frank K. Methods and compositions for oral insulin delivery
US20020131994A1 (en) 2001-01-10 2002-09-19 Schur Henry B. Non-irritating formulation for the transdermal delivery of substances
US6849271B2 (en) 2001-04-27 2005-02-01 Verion, Inc. Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods
TW576859B (en) 2001-05-11 2004-02-21 Shipley Co Llc Antireflective coating compositions
KR100428702B1 (ko) 2001-05-26 2004-04-28 주식회사 엘지생명과학 폴리에톡실화 알파 토코페롤 에스테르 유도체를 함유하는동물용 사료첨가제 조성물
KR100394770B1 (ko) 2001-06-05 2003-08-14 주식회사 태평양 토코페롤 유도체를 이용하여 나노유화입자를 안정화시키는방법 및 나노유화입자를 함유하는 피부 외용제 조성물
AU2002317053B2 (en) 2001-07-27 2004-08-05 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
AUPR684801A0 (en) 2001-08-06 2001-08-30 Vital Health Sciences Pty Ltd Supplement therapy
ES2299630T3 (es) 2001-09-04 2008-06-01 TROMMSDORFF GMBH & CO.KG ARZNEIMITTEL Emplastos para la profilaxis y/o el tratamiento de disfunciones o trastornos del crecimiento de las uñas.
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
EP1429744A1 (en) 2001-09-21 2004-06-23 Egalet A/S Morphine polymer release system
AU2002951045A0 (en) 2002-08-27 2002-09-12 Vital Health Sciences Pty Ltd Method of supplementing nascent endogenous storage forms
JP2005515969A (ja) 2001-09-26 2005-06-02 バイタル ヘルス サイエンシズ プロプライアタリー リミティド ビタミン貯蔵の調節
JP4370451B2 (ja) 2001-09-28 2009-11-25 大塚製薬株式会社 医薬組成物
JP2003128531A (ja) 2001-10-17 2003-05-08 Nonogawa Shoji Kk 皮膚外用剤
EP1450787A4 (en) 2001-11-15 2006-01-25 Galileo Pharmaceuticals Inc FORMULATIONS AND METHODS FOR THE TREATMENT OR AMELIORATION OF INFLAMMATORY CONDITIONS
WO2003049774A1 (en) * 2001-12-13 2003-06-19 Vital Health Sciences Pty Ltd Transdermal transport of compounds
CA2470920C (en) 2001-12-19 2013-04-02 Research Development Foundation Liposomal delivery of vitamin e based compounds
DE10200578A1 (de) 2002-01-09 2003-07-10 Roehm Gmbh Haft- und Bindemittel für dermale oder transdermale Therapiesysteme
US20040116514A1 (en) 2002-01-31 2004-06-17 Hoyoku Nishino Compositions for preventing human cancer and method of preventing human cancer
US20030220301A1 (en) 2002-02-14 2003-11-27 Sonus Pharmaceuticals, Inc. Metformin salts of lipophilic acids
US7074825B2 (en) 2002-03-07 2006-07-11 Huanbiao Mo Composition and method for treating cancer
AU2003224458A1 (en) 2002-05-09 2003-11-11 Showa Denko K.K. Skin whitening external preparation
WO2003097714A1 (en) 2002-05-20 2003-11-27 Ranbaxy Laboratories Limited Fat binding using inter-polymer complex of glucosamine and polyacrylic acid
US20040018237A1 (en) 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
BR0313060A (pt) 2002-07-29 2005-06-28 Transform Pharmaceuticals Inc Composições farmacêuticas aquosas de 2,6-diisopropilfenol
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US20040067890A1 (en) 2002-10-04 2004-04-08 Gupta Shyam K. Ascorbic acid salts of organic bases with enhanced bioavailability for synergictic anti-aging and skin protective cosmetic compositions
FR2846651B1 (fr) 2002-10-30 2006-06-16 Rhodia Polyamide Intermediates Procede de fabrication d'acides carboxyliques
US7399784B2 (en) 2002-11-26 2008-07-15 Children's Hospital & Research Center At Oakland Tocopherol and tocotrienol anti-obesity medicaments
US6645514B1 (en) 2002-12-19 2003-11-11 Access Business Group International, Llc Increasing skin cell renewal with water-soluble Vitamin E
BR0317876A (pt) 2002-12-31 2005-12-06 Nicholas V Perricone Composições de liberação de droga tópica estáveis
US20060241085A1 (en) 2003-01-17 2006-10-26 West Simon M Compounds having anti-proliferative properties
US7033998B2 (en) 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
AU2003901815A0 (en) 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
AU2003901813A0 (en) 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Pharmaceutical derivatives
AU2003901812A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphates of secondary alcohols
US20050152858A1 (en) 2003-07-11 2005-07-14 Isp Investments Inc. Solubilizing agents for active or functional organic compounds
US8546453B2 (en) 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
JP2006199589A (ja) 2003-09-03 2006-08-03 Ltt Bio-Pharma Co Ltd 生理活性タンパク質またはペプチドを含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる外用剤
CN100536845C (zh) 2003-09-23 2009-09-09 中国医学科学院药物研究所 氯雷他定透皮贴片
US7207669B2 (en) 2003-12-19 2007-04-24 Arizona Chemical Company Jet printing inks containing polymerized fatty acid-based polyamides
KR20170102377A (ko) 2004-01-22 2017-09-08 유니버시티 오브 마이애미 국소용 코-엔자임 큐10 제형 및 그의 사용 방법
US8383687B2 (en) 2004-02-13 2013-02-26 Medds, Inc. Microemulsion preparation of high concentration propofol for anesthetic uses
RS50963B (sr) 2004-02-23 2010-10-31 Euro-Celtique S.A. Opioidni transdermalni preparat otporan na zloupotrebu
EP1720551B9 (en) 2004-03-03 2011-09-21 Vital Health Sciences Pty Ltd. Alkaloid formulations
JP4758347B2 (ja) 2004-06-29 2011-08-24 独立行政法人科学技術振興機構 ヒアルロン酸を用いた小型肝細胞の選択的培養法および分離法
JP5198858B2 (ja) 2004-08-03 2013-05-15 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 腸内投与のための担体
JP4523388B2 (ja) 2004-11-19 2010-08-11 日本メナード化粧品株式会社 コラーゲン合成促進剤及び皮膚外用剤
US20060120979A1 (en) 2004-12-02 2006-06-08 Joel Rubin Skin care composition comprising hydroquinone and a substantially anhydrous base
WO2006092024A1 (en) 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
US20090239827A1 (en) 2005-03-03 2009-09-24 Esra Ogru Compounds having lipid lowering properties
KR20070108383A (ko) 2005-03-03 2007-11-09 바이탈 헬스 사이언시즈 피티와이 리미티드 지질 저하성 화합물
US20060228395A1 (en) 2005-04-11 2006-10-12 Robert Lamb Vitamin E phosphate/phosphatidylcholine liposomes to protect from or ameliorate cell damage
EP1893159B1 (en) 2005-06-17 2015-09-30 Vital Health Sciences Pty Ltd. A carrier comprising one or more di- and/or monophosphate derivatives of electron transfer agents
KR100764679B1 (ko) 2005-07-22 2007-10-09 익수제약 주식회사 파록세틴을 함유하는 경피투여용 패취제
US20070110739A1 (en) 2005-11-11 2007-05-17 Logsdon Lawrence M Wipe away pain
US7446096B2 (en) 2005-12-19 2008-11-04 Industrial Technology Research Institute Glutathione based delivery system
TW200800223A (en) 2005-12-21 2008-01-01 Shire Pharmaceuticals Inc Transdermal delivery of meptazinol
EP1973547A1 (en) 2005-12-23 2008-10-01 Vital Health Sciences Pty Ltd. Compounds having cytokine modulating properties
DE102006023336A1 (de) 2006-05-18 2007-11-22 Merck Patent Gmbh 1,5-Diphenyl-pyrazole II
WO2008034178A1 (en) 2006-09-21 2008-03-27 Salvatore Iemma Topical depilating composition
RU2373957C2 (ru) 2006-10-13 2009-11-27 Александр Метталинович Тишин Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его
AR064104A1 (es) 2006-12-05 2009-03-11 Novartis Ag Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlas
IL181217A0 (en) 2007-02-08 2007-07-04 Haim Levy Pharmaceuticalcompositions based on a microemulsion
FR2921259B1 (fr) 2007-09-26 2015-02-13 Lvmh Rech Utilisation cosmetique du phosphate de tocopherol comme agent anti-vieillissement de la peau
EP2113242A1 (en) 2008-05-02 2009-11-04 Pangaea Laboratories Limited Antioxidant for use in cosmetic, medicated and pharmaceutical preparations
US20090297591A1 (en) 2008-05-30 2009-12-03 Orient Pharma Co., Ltd. Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
AR072008A1 (es) 2008-06-13 2010-07-28 Merck & Co Inc Compuestos heterobiciclicos como agentes de inhibicion de quinasa p38
US20090319191A1 (en) 2008-06-24 2009-12-24 Rivas Ariel L Method for diagnosis of an infectious disease stage and determination of treatment
CN101524330B (zh) 2009-04-20 2013-01-09 重庆莱美药业股份有限公司 一种微乳载药系统及制备方法
CN102686279B (zh) 2009-12-23 2015-07-15 磷肌酸有限公司 载体组合物
EP2531047A4 (en) 2010-02-05 2014-03-19 Phosphagenics Ltd CARRIER WITH AN UNINUTRALIZED TOCOPHERYL PHOSPHATE
KR20120115991A (ko) 2010-02-05 2012-10-19 포스파제닉스 리미티드 담체 조성물
JP5132700B2 (ja) 2010-02-22 2013-01-30 三菱電機株式会社 手乾燥装置
ES2829386T3 (es) 2010-03-30 2021-05-31 Phosphagenics Ltd Parche de administración transdérmica
EP2648697A4 (en) 2010-12-10 2014-07-09 Ns Technologies Pty Ltd METHODS OF FORMING MINIEMULSIONS AND ASSOCIATED USE FOR ADMINISTRATION OF BIOACTIVE AGENTS
CN102079756B (zh) * 2010-12-27 2012-09-12 锦州惠发天合化学有限公司 一种全氟烷基聚氧乙烯基磷酸酯含氟表面活性剂的合成方法
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
US9328317B2 (en) * 2011-11-04 2016-05-03 The Chemours Company Fc, Llc Fluorophosphate surfactants
CN102911203A (zh) * 2012-10-25 2013-02-06 浙江合诚化学有限公司 一种烷基磷酸酯的制备方法
KR101542541B1 (ko) 2014-10-07 2015-08-06 주식회사 대동요업 역류 방지가 가능한 기와
CN108601732A (zh) 2015-12-09 2018-09-28 磷肌酸有限公司 药物制剂

Also Published As

Publication number Publication date
BR112019012946A2 (pt) 2019-11-26
JP7198754B2 (ja) 2023-01-04
AU2022201954B2 (en) 2023-12-21
US20220106353A1 (en) 2022-04-07
KR102647670B1 (ko) 2024-03-15
CN110662733A (zh) 2020-01-07
US11753435B2 (en) 2023-09-12
EP3558903A4 (en) 2019-11-27
IL267006A (en) 2019-07-31
RU2019119347A3 (es) 2021-04-16
KR20190100298A (ko) 2019-08-28
JP2020502193A (ja) 2020-01-23
RU2019119347A (ru) 2021-01-22
AU2017381395A1 (en) 2019-06-20
EP3558903A1 (en) 2019-10-30
US20190330260A1 (en) 2019-10-31
CA3045702A1 (en) 2018-06-28
AU2022201954A1 (en) 2022-04-14
WO2018112512A1 (en) 2018-06-28

Similar Documents

Publication Publication Date Title
PH12020550985A1 (en) Structural element
PH12016502586A1 (en) Lipid comprising docosapentaenoic acid
MX2022016566A (es) Composiciones que comprenden una caseina y metodos para producir las mismas.
JO3613B1 (ar) معزز واستخداماته
BR112017006295A2 (pt) microrganismos mutantes resistentes à morte por lactose
MX2016000634A (es) Metodo optimizado para la ruptura de paredes celulares de chlorella por medio de homogeneizacion a muy alta presion.
MX2017002214A (es) Proceso para la preparacion de 5-fluoro-1h-pirazoles partiendo de hexafluoropropeno.
TW201612153A (en) Producing method of (R)-1,1,3-trimethyl-4-aminoindane
MX2019007048A (es) Produccion de alcoholes grasos no saturados y acetatos de acilo grasos no saturados en la levadura.
WO2018093223A3 (ko) 엘더칼시톨의 제조방법 및 그를 위한 중간체
PH12015502396A1 (en) Method for producing olefin
MX2018004455A (es) Sistema y metodo para formar un diafragma con impresion tridimensional.
MX2019004182A (es) Proceso para la fabricacion de 2,6-dimetil-5-hepten-1-al.
MX2016005152A (es) Proceso para la preparacion de esteres insaturados.
MX2019004024A (es) Metodo para preparar acetofenonas sustituidas con ciclopropilo.
WO2016038560A9 (en) Process for the preparation of enzalutamide
EP3774706C0 (en) IMPROVED METHOD FOR CONVERTING PRIMARY ALIPHATIC ALCOHOLS INTO HIGHER ALIPHATIC ALCOHOLS
MX2019006845A (es) Proceso.
EA201692246A1 (ru) Способ получения 2,6-диметилбензохинона
MY180413A (en) Process for the decomposition of lignocellulose-containing biomass-material
MX2017002609A (es) Procedimiento mejorado para la preparacion de lacosamida y su intermediario novedoso.
MY175821A (en) Microorganism having ability to produce o-succinylhomoserine or succinic acid, and method for producing succinic acid or o-succinylhomoserine by using same
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2015016800A (es) Metodo para producir un contenedor de vidrio por medio de prensado.
GB201722064D0 (en) Polyvinyl alcohol antioxidant 1076 production plant